Is Ketamine Addictive?

Is Ketamine Addictive? What Young Adults (and Their Parents) Need to Know

Ketamine often makes headlines as a club drug, associated with parties, dissociation, and risk-taking. So it’s natural for young adults — and their parents — to ask:

“Is ketamine addictive?”

And more specifically: “If I pursue ketamine treatment for depression, will I get hooked?”

These are valid concerns, especially given ketamine’s reputation outside of medical settings. However, in a controlled clinical environment, the reality is more reassuring. When used responsibly under expert supervision, ketamine carries a very low risk of addiction.

Let’s separate fact from fear and explore what the research tells us.

Ketamine’s Abuse Risk in Recreational vs. Medical Use

First, it’s true that ketamine is a Schedule III controlled substance in the United States.^[1] This means it has recognized medical uses but also some potential for abuse, especially when used recreationally and without supervision.

In party settings, ketamine is sometimes misused for its hallucinogenic and dissociative effects, often in high doses and without any safeguards. Regular recreational use in these contexts can lead to psychological craving and dependence. 

But clinical treatment is an entirely different scenario. In supervised medical settings:

• Doses are carefully calculated and lower than recreational levels.
• Treatment frequency is limited and monitored — usually once or twice per week at most.^[2]
• No take-home doses are provided unless medically justified under strict protocols.
• Patients with active substance use disorders are typically excluded from treatment to prevent misuse.^[3]

These precautions help ensure that ketamine is used as a targeted intervention within a structured environment, minimizing the risk of abuse.

What Research Shows About Ketamine and Addiction Risk in Young Adults

Current clinical data is reassuring. Documented cases of new recreational misuse arising from medically supervised ketamine treatment for depression are rare, and the reviews that have looked for them describe the risk as low.^[4,5] Similarly, the FDA-approved version of ketamine, Spravato (esketamine), is only administered in certified clinics under direct observation.^[4,6,7] Some compelling support pieces to this are this systematic review of available literature and this scoping review of available study data.

Why Context and Supervision Matter for Ketamine Therapy

The question isn’t just “is ketamine addictive?” but rather, “under what conditions might ketamine become risky?”

Ketamine therapy is not without risks, but when administered by qualified clinicians within established safety protocols, the risk of addiction is very low. For young adults and their families weighing the benefits of ketamine or Spravato, this distinction between medical care and recreational abuse is essential.

At Lumin Health, we take this responsibility seriously. We screen all patients for substance use history, evaluate emotional and cognitive readiness, and provide structured, closely-monitored treatment environments. Patients are never left to navigate ketamine treatment alone.

If you or your loved one is considering ketamine treatment for depression, anxiety, or suicidality, know that clinical safeguards are in place to prioritize your safety, health, and long-term recovery.

Are you curious if ketamine treatment is the right next step for you? Contact us at Lumin Health to learn more about our comprehensive screening process, clinical supervision, and integration support for young adults.

References

1. World Health Organization. WHO Expert Committee on Drug Dependence. World Health Organ Tech Rep Ser. 2016;(998):1-34. PubMed
2. McIntyre RS, Rosenblat JD, Nemeroff CB, et al. Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation. Am J Psychiatry. 2021;178(5):383-399. PubMed
3. Sanacora G, Frye MA, McDonald W, et al. A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders. JAMA Psychiatry. 2017;74(4):399-405. PubMed
4. Le TT, Cordero IP, Jawad MY, et al. The abuse liability of ketamine: A scoping review of preclinical and clinical studies. J Psychiatr Res. 2022;151:476-496. PubMed
5. Jones JL, Mateus CF, Malcolm RJ, et al. Efficacy of Ketamine in the Treatment of Substance Use Disorders: A Systematic Review. Front Psychiatry. 2018;9:277. PubMed
6. Popova V, Daly EJ, Trivedi M, et al. Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study. Am J Psychiatry. 2019;176(6):428-438. PubMed
7. Fu DJ, Ionescu DF, Li X, et al. Esketamine Nasal Spray for Rapid Reduction of Major Depressive Disorder Symptoms in Patients Who Have Active Suicidal Ideation With Intent: Double-Blind, Randomized Study (ASPIRE I). J Clin Psychiatry. 2020;81(3). PubMed

Take the first step today.

If you or a loved one in Massachusetts and the greater Washington DC/Maryland area is struggling with depression or anxiety, Lumin Health's team of experts is ready to help. Book a free 20-minute consultation to learn if ketamine therapy could be the breakthrough you've been looking for.

Available in Massachusetts and the greater Washington DC/Maryland area.

Book Your Free Consultation

Frequently Asked Questions

Is ketamine addictive when used for medical treatment?

In a supervised medical setting, the risk is low. Doses are carefully calculated and lower than recreational levels, treatment is limited to about once or twice a week, and take-home doses aren't provided. Documented cases of new misuse arising from supervised treatment for depression are rare.

Is esketamine (Spravato) addictive?

Esketamine (Spravato) is administered only in certified practices under direct observation, which limits opportunity for misuse. It's a Schedule III controlled substance, meaning it has recognized medical use alongside some potential for abuse, but supervised, on-site dosing is designed to minimize that risk.

What is the difference between medical ketamine therapy and recreational use?

In medical care, doses are precisely calculated, treatment is monitored and limited in frequency, and people with active substance use disorders are typically screened out beforehand. Recreational use often involves high, unmonitored doses and other substances mixed in, which is where most of the real risk comes from.

What safety measures reduce the risk of ketamine misuse during treatment?

Before starting treatment, Lumin Health screens you for substance use history and evaluates your emotional and cognitive readiness. Sessions happen in a structured, closely monitored environment, and you're never navigating treatment alone.